Imricor Announces First Sales Collaboration With Philips
Imricor Medical Systems, Inc. (Company or Imricor ) (ASX:IMR ) the worldwide leader in MRI-guided cardiac ablation products, is pleased to announce the first sales collaboration with Philips , a global leader in healthcare technology.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200804005317/en/
The sales collaboration provides Philips non-exclusive rights to re-sell Imricor’s Advantage-MR System, along with Philips’ industry-leading MRI scanners in European countries that recognize the CE mark. This agreement is the first such agreement signed by Imricor.
Imricor’s Chair and CEO, Steve Wedan said: “This agreement is a major milestone for Imricor, allowing Philips to take the lead on driving iCMR lab adoption and enabling us to focus on supporting utilization, growing our portfolio of consumable devices and expanding our indications for use. In this way, we each leverage our strengths as we work together to deliver a new standard of care in the treatment of cardiac arrhythmias.”
The Imricor products are specifically designed to enable cardiac ablations under real-time MRI guidance. Imricor is the first and only company to offer a fully MR conditional EP recorder/stimulator system and cardiac ablation catheters for use in the MRI environment.
“Treatment procedures guided by MR represent an emerging field that extends the value of MR and complements established X-ray-based image-guided therapy systems,” said Arjen Radder, General Manager MR Business at Philips. “By working with Imricor we can support healthcare providers to offer MRI-guided cardiac ablation procedures for their patients.”
This collaboration is the latest achievement in the partnership between Imricor and Philips, which began in 2010.
“We are very proud to have a sales partnership with a company like Philips. We look forward to working with the talented Philips sales teams to leverage the extensive and outstanding relationships they have with customers, to help build new iCMR suites, and to identify potential customers that already have access to 1.5T compatible MRI systems.” Greg Englehardt, Director of Sales at Imricor.
Please visit http://imricor.com/investors/about-imricor/ for more information about Imricor, Foreign Ownership Restrictions, and Forward-Looking Statements.
About Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
ARGO-BLOCKCHAIN18.1.2021 09:48:48 CET | Press release
Argo Blockchain PLC announces £22.4 Million Private Placement with Institutional Investors and Mining Capacity Expansion
REPLY18.1.2021 09:32:47 CET | Press release
Reply Signs an Agreement with AWS to Develop Industry Solutions
L&T-TECHNOLOGY-SERVICES18.1.2021 09:02:44 CET | Press release
L&T Technology Services Rated as Global Pure-Play ER&D Services Leader by Zinnov
CA-GUARDANT-HEALTH18.1.2021 09:02:44 CET | Press release
Guardant Health and Vall d’Hebron Institute of Oncology Announce Partnership to Establish First Guardant-Based Liquid Biopsy Testing Service in Europe
NJ-TOPCON-HEALTHCARE18.1.2021 07:02:46 CET | Press release
Topcon Announces eyeRISE 2021 Virtual Symposia & Expo
SERVIER16.1.2021 22:17:39 CET | Press release
Servier announce updated overall survival results of exploratory TASCO1 phase II study of LONSURF® + bevacizumab in a first-line setting for patients with unresectable mCRC non-eligible for intensive therapy
CA-ANDERSEN-GLOBAL15.1.2021 11:01:39 CET | Pressemeddelelse
Andersen Global træder ind i Sverige i samarbejde med Unum Tax
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom